MoneyWorks4Me

Everest Organics - Quaterly Results

27 May 2024 Evaluate
A minor change in the total revenue was seen in the March 2024 quarter. The total revenue for the quarter stood at Rs. 526.17 millions against Rs. 507.54 millions during year ago period.A big decline of -48.67% was reported for the quarter ended March 2024 to Rs. 0.58  millions from Rs. 1.13 millions of corresponding previous quarter.Operating profit surged to 32.57 millions from the corresponding previous quarter of 29.69 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 526.17 507.54 3.67 1972.41 1830.48 7.75 1972.41 1830.48 7.75
Other Income 2.97 6.89 -56.89 8.86 69.44 -87.24 8.86 69.44 -87.24
PBIDT 32.57 29.69 9.70 118.72 78.73 50.79 118.72 78.73 50.79
Interest 12.43 9.52 30.57 54.66 33.10 65.14 54.66 33.10 65.14
PBDT 20.14 20.17 -0.15 64.06 45.63 40.39 64.06 45.63 40.39
Depreciation 18.52 12.59 47.10 57.95 44.74 29.53 57.95 44.74 29.53
PBT 1.62 7.58 -78.63 6.11 0.89 586.52 6.11 0.89 586.52
TAX 1.04 6.45 -83.88 4.71 2.72 73.16 4.71 2.72 73.16
Deferred Tax 0.74 6.30 -88.25 3.71 2.57 44.36 3.71 2.57 44.36
PAT 0.58 1.13 -48.67 1.40 -1.83 -176.50 1.40 -1.83 -176.50
Equity 80.00 80.00 0.00 80.00 80.00 0.00 80.00 80.00 0.00
PBIDTM(%) 6.19 5.85 5.82 6.02 4.30 39.94 6.02 4.30 39.94
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..